You know this trial is a double-blinded control trial right? The data doesn't get unlocked prior to complete patient enrolment and after the last time-point. This extension is not a reflection of "quality data" being seen. This (as they stated), is due to feedback from KOL's that twice weekly injections isn;t commercially appetising, hence they're trying once a week. IMO
- Forums
- ASX - By Stock
- Ann: Phase 2 Synovial Fluid Biomarker Study Update
You know this trial is a double-blinded control trial right? The...
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M |
Open | High | Low | Value | Volume |
25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 181098 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 118621 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 118000 | 0.240 |
4 | 27745 | 0.235 |
1 | 25000 | 0.230 |
2 | 6262 | 0.225 |
6 | 48629 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 64601 | 3 |
0.255 | 50000 | 1 |
0.260 | 21333 | 2 |
0.265 | 69367 | 4 |
0.270 | 53000 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online